Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative Anti-tuberculosis Treatment Duration in Spinal Tuberculosis
NCT02477852Phase 4Unknown
- Sponsor
- Beijing Chest Hospital
- Start
- Apr 2015
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of isoniazid, rifampicin, ethambutol, pyrazinamide in spinal tuberculosis, sponsored by Beijing Chest Hospital. Status: unknown.
02
Drugs
isoniazidrifampicinethambutolpyrazinamide
03
Conditions
spinal tuberculosis
Beyond the preview
Go deeper on NCT02477852.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02477852.